International Biotechnology Trust’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-319,989
| Closed | -$7.41M | – | 76 |
|
|
2023
Q1 | $7.41M | Sell |
319,989
-20,400
| -6% | -$472K | 2.07% | 17 |
|
|
2022
Q4 | $8.91M | Hold |
340,389
| – | – | 2.75% | 12 |
|
|
2022
Q3 | $6.69M | Buy |
340,389
+334,442
| +5,624% | +$6.57M | 2.14% | 16 |
|
|
2022
Q2 | $340K | Sell |
5,947
-334,442
| -98% | -$19.1M | 3.55% | 9 |
|
|
2022
Q1 | $4.71M | Buy |
340,389
+51,000
| +18% | +$706K | 1.06% | 30 |
|
|
2021
Q4 | $4.71M | Buy |
289,389
+54,389
| +23% | +$886K | 1.05% | 30 |
|
|
2021
Q3 | $2.99M | Buy |
235,000
+64,179
| +38% | +$817K | 0.72% | 31 |
|
|
2021
Q2 | $2.41M | Buy |
+170,821
| New | +$2.41M | 0.64% | 36 |
|